GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncolys BioPharma Inc (TSE:4588) » Definitions » Cyclically Adjusted Book per Share

Oncolys BioPharma (TSE:4588) Cyclically Adjusted Book per Share : 円273.75 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Oncolys BioPharma Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Oncolys BioPharma's adjusted book value per share for the three months ended in Mar. 2024 was 円84.141. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円273.75 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Oncolys BioPharma's average Cyclically Adjusted Book Growth Rate was -8.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-05-28), Oncolys BioPharma's current stock price is 円645.00. Oncolys BioPharma's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was 円273.75. Oncolys BioPharma's Cyclically Adjusted PB Ratio of today is 2.36.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Oncolys BioPharma was 2.71. The lowest was 1.71. And the median was 2.04.


Oncolys BioPharma Cyclically Adjusted Book per Share Historical Data

The historical data trend for Oncolys BioPharma's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncolys BioPharma Cyclically Adjusted Book per Share Chart

Oncolys BioPharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 285.86

Oncolys BioPharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 298.89 300.88 297.97 285.86 273.75

Competitive Comparison of Oncolys BioPharma's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Oncolys BioPharma's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oncolys BioPharma's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncolys BioPharma's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Oncolys BioPharma's Cyclically Adjusted PB Ratio falls into.



Oncolys BioPharma Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Oncolys BioPharma's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=84.141/107.2000*107.2000
=84.141

Current CPI (Mar. 2024) = 107.2000.

Oncolys BioPharma Quarterly Data

Book Value per Share CPI Adj_Book
201406 525.120 98.000 574.417
201409 507.879 98.500 552.737
201412 476.031 97.900 521.252
201503 453.340 97.900 496.405
201506 431.249 98.400 469.816
201509 409.505 98.500 445.674
201512 381.266 98.100 416.633
201603 358.801 97.900 392.885
201606 332.191 98.100 363.006
201609 297.639 98.000 325.581
201612 283.432 98.400 308.780
201703 281.835 98.100 307.979
201706 291.225 98.500 316.947
201709 288.471 98.800 312.997
201712 264.468 99.400 285.221
201803 234.244 99.200 253.135
201806 206.581 99.200 223.241
201809 227.387 99.900 244.003
201812 217.380 99.700 233.733
201903 194.276 99.700 208.891
201906 280.071 99.800 300.838
201909 257.873 100.100 276.164
201912 241.267 100.500 257.351
202003 221.110 100.300 236.321
202006 195.020 99.900 209.271
202009 161.168 99.900 172.945
202012 136.957 99.300 147.853
202103 275.431 99.900 295.558
202106 258.614 99.500 278.627
202109 239.645 100.100 256.643
202112 207.305 100.100 222.009
202203 171.848 101.100 182.217
202206 157.910 101.800 166.286
202209 142.643 103.100 148.316
202212 124.648 104.100 128.360
202303 105.962 104.400 108.804
202306 74.497 105.200 75.913
202309 73.053 106.200 73.741
202312 75.100 106.800 75.381
202403 84.141 107.200 84.141

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Oncolys BioPharma  (TSE:4588) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Oncolys BioPharma's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=645.00/273.75
=2.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Oncolys BioPharma was 2.71. The lowest was 1.71. And the median was 2.04.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Oncolys BioPharma Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Oncolys BioPharma's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Oncolys BioPharma (TSE:4588) Business Description

Industry
Traded in Other Exchanges
N/A
Address
4-1-28 Toranomon, Toranomon Towers Office, Minato-ku, Tokyo, JPN, 105-0001
Oncolys BioPharma Inc develops pharmaceutical products. The company is engaged in research and development of oncolytic viruses, drugs for serious infectious diseases, molecular targeted anti-cancer drugs, and tumor diagnostic agents.

Oncolys BioPharma (TSE:4588) Headlines

No Headlines